Delivery Order SPE2DB22D3501-SPE2DB25FXK06
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Leuprolide 2-week 14 mg/2.8 mL kits with a firm fixed price ceiling value of $39,070.90. This is a non-set-aside, competitively awarded delivery order to be performed at the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of August 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- This is a $24,928.48 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides for the delivery of 4,564,639,914 units of leuprolide 2-week 14 mg/2.8 ml kits to support military healthcare programs. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which serves as a primary vehicle for...
- The Defense Logistics Agency Troop Support Medical awarded a $485,840 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561830844 LEUPROLIDE 2WK 14 MG/2.8 ML KITS. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is from August 16, 2023 through August 17, 2023. This delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,178.10 award is for the delivery of the pharmaceutical product leuprolide 2-week 14 mg/2.8 mL kits. The order is part of a larger indefinite delivery contract (IDC) with a potential value of up to $999,999,999.00 awarded to Amerisourcebergen Drug Corp,...
- The Defense Logistics Agency awarded a $480,660 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561308601 Leuprolide 2wk 14 mg/2.8 ml kits. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will fulfill the order from its place of performance in Conshohocken, Pennsylvania. The delivery order was awarded under an unspecified indefinite-delivery/indefinite-quantity contract vehicle to support the Defense Logistics...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,423,235 units of the pharmaceutical product LEUPROLIDE 2WK 14 MG/2.8 ML KTS. The delivery order, which has a potential value of $23,373.98, was issued without any set-aside designation and has a completion date of January 25, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has...
- The Defense Logistics Agency (DLA) awarded a $17,899.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lupron Depot 3.75 mg kits, with an ultimate completion date of July 22, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a $17,214.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lupron Depot-Ped 15 mg kits on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-set-aside award was made competitively and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The products will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lupron Depot 3.75 mg kits on September 8, 2025, with a ceiling value of $5,107.77. This is a firm fixed-price contract with no set-aside designation, and performance will be completed by September 9, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $24,494.37 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply LEUPROLIDE 2WK 14 MG/2.8 ML KITS. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by November 7, 2023. No set-aside designation was applied to this award made against an indefinite delivery contract held by Amerisourcebergen Drug Corp to...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXK06Delivery Order
The Defense Logistics Agency awarded a $4,243.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Leuprolide 2-week 14 mg/2.8 ml kits, with an ultimate completion date of September 18, 2025. This non-set-aside contract, awarded on September 17, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order supports the Defense Logistics Agency's critical mission to supply pharmaceutical products and medical commodities to military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a prime vendor through its comprehensive global pharmaceutical support vehicle, enabling the supply of specialty medications, brand-name and generic drugs, and related medical supplies across multiple therapeutic domains. The leuprolide kits being procured under this order support hormone-based treatments within the military's medical supply chain, serving customers including the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 9/17/25 |